NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,171 filers reported holding NOVARTIS A G in Q4 2022. The put-call ratio across all filers is 0.50 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,009 | +9.7% | 10 | 0.0% | 0.00% | – |
| Q1 2023 | $920 | +1.4% | 10 | 0.0% | 0.00% | – |
| Q4 2022 | $907 | -9.3% | 10 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 10 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | -50.0% | 10 | -50.0% | 0.00% | – |
| Q1 2022 | $2,000 | -88.9% | 20 | -90.5% | 0.00% | -100.0% |
| Q4 2021 | $18,000 | +1700.0% | 210 | +2000.0% | 0.01% | – |
| Q3 2021 | $1,000 | 0.0% | 10 | 0.0% | 0.00% | -100.0% |
| Q2 2021 | $1,000 | 0.0% | 10 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $1,000 | -50.0% | 10 | -50.0% | 0.00% | 0.0% |
| Q4 2020 | $2,000 | -89.5% | 20 | -90.8% | 0.00% | -92.9% |
| Q3 2020 | $19,000 | -9.5% | 217 | -8.4% | 0.01% | -12.5% |
| Q2 2020 | $21,000 | +5.0% | 237 | 0.0% | 0.02% | -15.8% |
| Q1 2020 | $20,000 | -9.1% | 237 | 0.0% | 0.02% | 0.0% |
| Q4 2019 | $22,000 | – | 237 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
| Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
| SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
| MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
| GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
| PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
| WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
| First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
| Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
| JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |